An innovative one-time treatment that harnesses a patient’s own immune system to fight advanced melanoma could help people with the deadly form of skin cancer live longer, researchers have suggested.
Lifileucel is a tumour-infiltrating lymphocyte (TIL) therapy, which involves isolating T cells – a type of white blood cell – from tumours and growing them in a lab before infusing them back into the patient where they can recognise and fight cancer.
